The use of Yttrium-90 Ibritumomab Tiuxetan ( 90 Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation - Publication - Bridge of Knowledge

Search

The use of Yttrium-90 Ibritumomab Tiuxetan ( 90 Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation

Abstract

Citations

  • 1

    CrossRef

  • 0

    Web of Science

  • 4

    Scopus

Authors (6)

  • Photo of MD, PhD, Prof Wojciech Jurczak

    Wojciech Jurczak MD, PhD, Prof

  • Photo of  Elżbieta Kisiel

    Elżbieta Kisiel

  • Photo of  Joanna Sawczuk-Chabin

    Joanna Sawczuk-Chabin

  • Photo of  Piotr Centkowski

    Piotr Centkowski

  • Photo of  Wanda Knopińska-Posłuszny

    Wanda Knopińska-Posłuszny

  • Photo of  Omeir Khan

    Omeir Khan

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
Wspolczesna Onkologia-Contemporary Oncology no. 1, pages 43 - 47,
ISSN: 1428-2526
ISSN:
1428-2526
Publication year:
2015
DOI:
Digital Object Identifier (open in new tab) 10.5114/wo.2015.50012
Verified by:
No verification

seen 31 times

Meta Tags